February 9, 2012 -- Takeda Pharma has established a new China division, Takeda Shanghai Development Center, which will be put in charge of the company’s clinical development projects in Asia. The TSDC will concentrate on general medicine in China and oncology for all of Asia. It will conduct clinical trials – increasing the emphasis on China – and it will also be given the task of deepening relationships with physicians and drug regulators. More details....
Stock Symbol: (TO: 4502)
